BioDelivery Sciences International (BDSI) Provides Business Review and Update in Conjunction with Filing of First Quarter 2013 Financials
5/10/2013 6:56:41 AM
More...
|
BioDelivery Sciences International (BDSI) to Present at the Bank of America (BAC) Merrill Lynch 2013 Health Care Conference
5/7/2013 6:46:09 AM
More...
|
BioDelivery Sciences International (BDSI) Appoints Thomas W. D'Alonzo to Board of Directors
4/29/2013 7:00:57 AM
More...
|
BioDelivery Sciences International (BDSI) Pays Up to $40 Million for Pain Drug Candidate
3/26/2013 7:09:30 AM
More...
|
BioDelivery Sciences International (BDSI) Provides Business Review and Update in Conjunction With Filing of Its 2012 Annual Report
3/19/2013 9:35:09 AM
More...
|
BioDelivery Sciences International (BDSI) to Present at the 25th Annual ROTH Conference
3/13/2013 7:04:19 AM
More...
|
BioDelivery Sciences International (BDSI) to Present at the Cowen and Company 33rd Annual Health Care Conference
3/1/2013 7:51:02 AM
More...
|
BioDelivery Sciences International (BDSI) to Host Buprenorphine Investor and Analyst Event
2/27/2013 7:08:43 AM
More...
|
BioDelivery Sciences International (BDSI) to Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO and Investor Conference
2/5/2013 6:52:09 AM
More...
|
BioDelivery Sciences International (BDSI) Announces Completion of BNX Safety Study
1/22/2013 9:48:04 AM
More...
|
|